Alpha Centric Advisors LLC Mirum Pharmaceuticals, Inc. Transaction History
Alpha Centric Advisors LLC
- $118 Million
- Q3 2024
A detailed history of Alpha Centric Advisors LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 45,000 shares of MIRM stock, worth $1.85 Million. This represents 1.48% of its overall portfolio holdings.
Number of Shares
45,000
Previous 64,000
29.69%
Holding current value
$1.85 Million
Previous $2.19 Million
19.79%
% of portfolio
1.48%
Previous 1.81%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$271 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$184 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$142 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$133 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$127 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.51B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...